Ress Life Investments A/S: Ress Uncorrelated Assets Fund provides portfolio composition update

16 september 2016

Ress Life Investments A/S
Holbergsgade 14, 2 tv
DK-1057 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 16 September 2016

Corporate Announcement 29/2016

Ress Uncorrelated Assets Fund provides portfolio composition update

Ress Life Investments A/S acts as a feeder and invests in fund units of the master fund, Ress Uncorrelated Assets Fund. The AIF-manager of the master fund has provided the following information.

As of 31 August, the portfolio of the master fund included 206 policies with a total face value of USD 407 930 825. Below is a breakdown of the portfolio composition along different categories.

Top Carriers	Weight%
John Hancock Life Insurance Company USA	14.9%
AXA Equitable Life Insurance Company	8.4%
Lincoln National Life Insurance Company	8.1%
Transamerica Life Insurance Company	6.2%
Protective Life Insurance Company	5.9%
MetLife Insurance Company USA	5.0%
Security Life Of Denver Insurance Company	4.1%
C.M. Life Insurance Company	3.9%
Lincoln Benefit Life Insurance Company	3.8%
American General Life Insurance Company	3.7%

Age Group	Weight%
<65	0.1%
65-69	3.3%
70-74	22.0%
75-79	39.3%
80-84	24.1%
85-89	10.7%
90-94	0.6%

Carrier Rating	Weight%
A++	6.4%
A+	70.4%
A	12.6%
A-	10.5%
Top States	Weight%
FL	16.6%
CA	15.8%
NY	10.7%
TX	5.3%
IL	4.0%
NJ	2.9%
NC	1.9%
TN	1.2%
WA	0.4%
OK	0.1%

Gender	Weight%
Female	29.4%
Male	70.6%

Mortality Rating/Multiplier	Weight%
<100	25.8%
100-150	47.5%
150-200	13.5%
200-250	3.3%
250-300	3.2%
300-350	1.8%
350-400	2.6%
400-	2.3%

BMI Group	Weight%
Underweight	1.8%
Normal	30.6%
Overweight	37.5%
Obese Class I	20.2%
Obese Class II	7.4%
Obese Class III	2.5%

Blood pressure	Weight%
Hypotension	7.6%
Normal	15.2%
Prehypertension	52.1%
Stage 1 Hypertension	21.5%
Stage 2 Hypertension	3.5%

Life Expectancy	Weight%
< 2	0.1%
2-3	0.6%
4-5	2.5%
6-7	9.1%
8-9	20.8%
10-11	33.2%
12-15	22.3%
16-	11.5%

Impairment Category	Weight%
Endocrine/Metabolic	21.5%
Gastro Intestinal	14.2%
Cardiac	13.6%
Musculoskeletal	10.8%
Genito-Urinary	5.9%
Dermatologic Cond.	5.6%
ENT	5.3%
Ophthalmologic Diseases	4.4%
Pulmonary	4.3%
Hematology	3.0%
Psychiatric Disorders	2.7%
Renal	1.8%
Oncology	1.7%
Cerebro-Vascular	1.6%
Neurology	1.2%
Vascular Disorders	0.7%
Infectious Disease	0.7%
Miscellaneous	0.5%
Gynecological Cond.	0.3%
Psychiatric	0.2%
Rheumatologic/Immuno	0.1%

Category	Sub-category breakdown	Weight%
Endocrine/Metabolic	Dyslipidemia -- Lipid Profile	12.7%
Cardiac	Hypertension(HTN) -- Controlled HTN	8.7%
Endocrine/Metabolic	Diabetes Mellitus -- Type 2 Diabetes Mellitus	4.6%
Musculoskeletal	Bone Density -- Osteopenia	3.8%
Ophthalmologic Diseases	Cataracts	3.5%
Endocrine/Metabolic	Thyroid Disease -- Hypothyroidism	3.3%
Gastro Intestinal	Polyps -- Colon polyps	2.6%
Genito-Urinary	ED	2.3%
Dermatologic Cond.	Squamous Cell Carcinoma	2.2%
Dermatologic Cond.	Keratosis -- Actinic Keratosis	2.1%
Cardiac	Atrial Fibrillation -- A-Fib Considered	1.8%
Psychiatric Disorders	Depression -- Depression (Mild/Unspecified)	1.8%
ENT	Allergy -- Allergic rhinitis	1.6%
Gastro Intestinal	Hemorrhoids -- Internal Hemorrhoids	1.3%
Pulmonary	Sleep Apnea	1.3%
Ophthalmologic Diseases	Glaucoma	0.9%
Endocrine/Metabolic	Gout	0.8%
Oncology	Prostate Cancer -- Grade 2: Gleason 5-7	0.6%
Gastro Intestinal	Liver -- Fatty Liver	0.6%
Cerebro-Vascular	Carotid Disease	0.5%
Cerebro-Vascular	Stroke/CVA	0.5%
ENT	Ear Disorders (Vestibulo-Cochlear)	0.4%
Pulmonary	URI	0.4%
Gastro Intestinal	Ulcerative Colitis	0.1%
Gastro Intestinal	GERD -- Mild GERD	0.1%
Pulmonary	COPD -- Symptoms of COPD	0.1%
Oncology	Colon/Rectal Cancer	0.1%
Rheumatologic/Immuno	Rheumatoid Arthritis	0.1%
Ophthalmologic Diseases	Macular Degeneration	0.1%
Gastro Intestinal	Polyps -- Polypectomy	0.1%

Questions related to this announcement can be made to the company's AIF-manager, Resscapital AB.

Contact person:
Jonas Mårtenson
jonas.martenson@resscapital.com
Tel + 46 8 545 282 09

---